Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Melio
Melio is developing a rapid, comprehensive bloodborne pathogen testing platform that identifies 99% of common pathogens directly from blood without requiring blood culture. Their technology…
Melio
Melio is developing a rapid, comprehensive bloodborne pathogen testing platform that identifies 99% of common pathogens directly from blood without requiring blood culture. Their technology…
TL;DR
Product: Culture‑free, direct‑from‑blood pathogen testing platform delivering results in hours
Technology: Proprietary assays + microfluidics + AI/ML (pathogen‑agnostic, software‑driven updates)
Stage: In development; not yet commercialized
Founded: 2018
Company Overview
Problem Domain
Bloodborne pathogen diagnostics; reducing time to identification compared with traditional blood culture
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
7500000
Funding information present in company snapshot evidence
Investor Signal
“CARB-X, IndieBio, Consortium For Technology & Innovation in Pediatrics, Lexi Ventures, LongeVC, SOSV, Vye Ventures”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
500+
New This Week